Nivorozhkin A - Search Results

1

Synthesis and Structure-Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT₂ Receptor Agonist.

Varty GB, Canal CE, Mueller TA, Hartsel JA, Tyagi R, Avery K, Morgan ME, Reichelt AC, Pathare P, Stang E, Palfreyman MG, Nivorozhkin A. Varty GB, et al. Among authors: nivorozhkin a. J Med Chem. 2024 Apr 25;67(8):6144-6188. doi: 10.1021/acs.jmedchem.3c01961. Epub 2024 Apr 9. J Med Chem. 2024. PMID: 38593423

2

[Challenges and Adaptation Strategies of Service Providers in Vocational Rehabilitation - A Mixed-Methods Analysis].

Reims N, Rauch A, Nivorozhkin A. Reims N, et al. Among authors: nivorozhkin a. Rehabilitation (Stuttg). 2023 Aug;62(4):207-215. doi: 10.1055/a-2053-6763. Epub 2023 Apr 6. Rehabilitation (Stuttg). 2023. PMID: 37023766 Free PMC article. German.

3

Working conditions in essential occupations and the role of migrants.

Nivorozhkin A, Poeschel F. Nivorozhkin A, et al. Econ Anal Policy. 2022 Jun;74:250-261. doi: 10.1016/j.eap.2022.02.002. Epub 2022 Feb 14. Econ Anal Policy. 2022. PMID: 36250104 Free PMC article.

4

Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach.

Liu H, Rivnay B, Avery K, Myung JH, Kozak D, Landrau N, Nivorozhkin A, Ashraf M, Yoon S. Liu H, et al. Among authors: nivorozhkin a. Int J Pharm. 2020 Jul 30;585:119473. doi: 10.1016/j.ijpharm.2020.119473. Epub 2020 May 27. Int J Pharm. 2020. PMID: 32473373

5

Critical process parameters in manufacturing of liposomal formulations of amphotericin B.

Rivnay B, Wakim J, Avery K, Petrochenko P, Myung JH, Kozak D, Yoon S, Landrau N, Nivorozhkin A. Rivnay B, et al. Among authors: nivorozhkin a. Int J Pharm. 2019 Jun 30;565:447-457. doi: 10.1016/j.ijpharm.2019.04.052. Epub 2019 May 6. Int J Pharm. 2019. PMID: 31071418

6

[Vocational Rehabilitation - Comparing Clients of the Federal Employment Agency and the German Pension Insurance].

Nivorozhkin A, Reims N, Zollmann P, Bethge M. Nivorozhkin A, et al. Rehabilitation (Stuttg). 2018 Jun;57(3):149-156. doi: 10.1055/a-0608-8879. Epub 2018 Jun 20. Rehabilitation (Stuttg). 2018. PMID: 29925114 German.

7

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Pacher P, Nivorozhkin A, Szabó C. Pacher P, et al. Among authors: nivorozhkin a. Pharmacol Rev. 2006 Mar;58(1):87-114. doi: 10.1124/pr.58.1.6. Pharmacol Rev. 2006. PMID: 16507884 Free PMC article. Review.

8

Facile and convenient syntheses of 6,11-dihydro-5H-indeno[1,2-c]isoquinolin- 5-ones and 6,11-dihydro-5H-indolo[3,2-c]isoquinolin-5-one.

Jagtap PG, Baloglu E, Southan G, Williams W, Roy A, Nivorozhkin A, Landrau N, Desisto K, Salzman AL, Szabó C. Jagtap PG, et al. Among authors: nivorozhkin a. Org Lett. 2005 Apr 28;7(9):1753-6. doi: 10.1021/ol050331m. Org Lett. 2005. PMID: 15844898

9

Metallocyclopeptide complexes with MII(S.Cys)4 chromophores.

Nivorozhkin AL, Segal BM, Musgrave KB, Kates SA, Hedman B, Hodgson KO, Holm RH. Nivorozhkin AL, et al. Inorg Chem. 2000 May 29;39(11):2306-13. doi: 10.1021/ic990421l. Inorg Chem. 2000. PMID: 12526490

10

Enzyme-Activated Gd(3+) Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor-Induced Magnetization Enhancement We thank Dr. Shrikumar Nair for helpful discussions.

Nivorozhkin AL, Kolodziej AF, Caravan P, Greenfield MT, Lauffer RB, McMurry TJ. Nivorozhkin AL, et al. Angew Chem Int Ed Engl. 2001 Aug 3;40(15):2903-2906. Angew Chem Int Ed Engl. 2001. PMID: 11500904 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters